{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:35Z","timestamp":1787032895481,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,30]]},"DOI":"10.7759\/cureus.76631","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:07:26Z","timestamp":1735560446000},"source":"Crossref","is-referenced-by-count":2,"title":["Pain Management in Fibromyalgia: Evaluating the Roles of Pregabalin, Duloxetine, and Milnacipran"],"prefix":"10.7759","author":[{"given":"Khawaja","family":"Faizan Ejaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qudsia","family":"Umaira Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hifza","family":"Ishtiaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Iqbal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25532","article-title":"Milnacipran for the treatment of fibromyalgia","volume":"9","author":"Gupta H","year":"2021","unstructured":"Gupta H, Girma B, Jenkins JS, Kaufman SE, Lee CA, Kaye AD. Milnacipran for the treatment of fibromyalgia. Health Psychol Res. 2021, 9:25532. 10.52965\/001c.25532","journal-title":"Health Psychol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-03995-z","article-title":"Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis","volume":"18","author":"Migliorini F","year":"2023","unstructured":"Migliorini F, Maffulli N, Eschweiler J, Baroncini A, Bell A, Colarossi G. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis. J Orthop Surg Res. 2023, 18:504. 10.1186\/s13018-023-03995-z","journal-title":"J Orthop Surg Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1017129","article-title":"Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials","volume":"13","author":"Alorfi NM","year":"2022","unstructured":"Alorfi NM. Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials. Front Pharmacol. 2022, 13:1017129. 10.3389\/fphar.2022.1017129","journal-title":"Front Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and us food and drug administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag HM","year":"2022","unstructured":"Farag HM, Yunusa I, Goswami H, Sultan I, Doucette JA, Eguale T. Comparison of amitriptyline and us food and drug administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis. JAMA Netw Open. 2022, 5:e2212939. 10.1001\/jamanetworkopen.2022.12939","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0803-z","article-title":"Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review","volume":"23","author":"Urits I","year":"2019","unstructured":"Urits I, Peck J, Orhurhu MS, et al.. Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review. Curr Pain Headache Rep. 2019, 23:66. 10.1007\/s11916-019-0803-z","journal-title":"Curr Pain Headache Rep"},{"key":"ref6","article-title":"A comparative study on the evaluation of pregabalin versus duloxetine and the prescribing trends in patients with fibromyalgia syndrome","volume":"7","author":"George M","year":"2018","unstructured":"George M, Joseph L, Manuel A, Chacko AK, Boban BR, Joy M. A comparative study on the evaluation of pregabalin versus duloxetine and the prescribing trends in patients with fibromyalgia syndrome. World J Pharm Res. 2018, 7:14.","journal-title":"World J Pharm Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S162810","article-title":"Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study","volume":"12","author":"Pickering G","year":"2018","unstructured":"Pickering G, Macian N, Delage N, et al.. Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study. Drug Des Devel Ther. 2018, 12:2485-96. 10.2147\/DDDT.S162810","journal-title":"Drug Des Devel Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6541798","article-title":"Current and emerging pharmacotherapy for fibromyalgia","volume":"2020","author":"Tzadok R","year":"2020","unstructured":"Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020, 2020:6541798. 10.1155\/2020\/6541798","journal-title":"Pain Res Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061266","article-title":"Management of fibromyalgia: an update","volume":"12","author":"Jones EA","year":"2024","unstructured":"Jones EA, Asaad F, Patel N, Jain E, Abd-Elsayed A. Management of fibromyalgia: an update. Biomedicines. 2024, 12:1266. 10.3390\/biomedicines12061266","journal-title":"Biomedicines"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01277-9","article-title":"Pharmacological treatment of fibromyalgia syndrome: a practice-based review","volume":"28","author":"Giorgi V","year":"2024","unstructured":"Giorgi V, Sarzi-Puttini P, Pellegrino G, et al.. Pharmacological treatment of fibromyalgia syndrome: a practice-based review. Curr Pain Headache Rep. 2024, 28:1349-63. 10.1007\/s11916-024-01277-9","journal-title":"Curr Pain Headache Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar CC","year":"2021","unstructured":"Serdar CC, Cihan M, Y\u00fccel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021, 31:010502. 10.11613\/BM.2021.010502","journal-title":"Biochem Med (Zagreb)"},{"key":"ref12","unstructured":"How sample size calculations are reported in the literature. (2012). Accessed. December 16, 2024: http:\/\/www.pmean.com\/12\/PowerStatements.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009796.pub2","article-title":"Cognitive behavioural therapies for fibromyalgia","volume":"2013","author":"Bernardy K","year":"2013","unstructured":"Bernardy K, Klose P, Busch AJ, Choy EH, H\u00e4user W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013, 2013:CD009796. 10.1002\/14651858.CD009796.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/03331024111430856","article-title":"Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache","volume":"32","author":"Aicher B","year":"2012","unstructured":"Aicher B, Peil H, Peil B, Diener HC. Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 2012, 32:185-97. 10.1177\/03331024111430856","journal-title":"Cephalalgia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-43044-9.00170-9","article-title":"Fibromyalgia syndrome: under-, over-, and misdiagnosis","volume":"37","author":"H\u00e4user W","year":"2019","unstructured":"H\u00e4user W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over-, and misdiagnosis. Clin Exp Rheumatol. 2019, 37:90-7. 10.1016\/B978-0-323-43044-9.00170-9","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse DJ","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213. 10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr006","article-title":"Short form 36 (SF-36) health survey questionnaire: normative data for Wales","volume":"33","author":"Burholt V","year":"2011","unstructured":"Burholt V, Nash P. Short form 36 (SF-36) health survey questionnaire: normative data for Wales. J Public Health (Oxf). 2011, 33:587-603. 10.1093\/pubmed\/fdr006","journal-title":"J Public Health (Oxf)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-018-0933-z","article-title":"Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU","volume":"22","author":"Gentile S","year":"2019","unstructured":"Gentile S, Fusco ML. Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU. Arch Womens Ment Health. 2019, 22:711-21. 10.1007\/s00737-018-0933-z","journal-title":"Arch Womens Ment Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2365326","article-title":"Pharmacotherapeutic advances in fibromyalgia: what's new on the horizon?","volume":"25","author":"Sarzi-Puttini P","year":"2024","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, et al.. Pharmacotherapeutic advances in fibromyalgia: what's new on the horizon?. Expert Opin Pharmacother. 2024, 25:999-1017. 10.1080\/14656566.2024.2365326","journal-title":"Expert Opin Pharmacother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.03.011","article-title":"Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia","volume":"827","author":"Kiso T","year":"2018","unstructured":"Kiso T, Moriyama A, Furutani M, Matsuda R, Funatsu Y. Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia. Eur J Pharmacol. 2018, 827:117-24. 10.1016\/j.ejphar.2018.03.011","journal-title":"Eur J Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292.pub2","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia","volume":"2","author":"Welsch P","year":"2018","unstructured":"Welsch P, \u00dc\u00e7eyler N, Klose P, Walitt B, H\u00e4user W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018, 2:CD010292. 10.1002\/14651858.CD010292.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5935\/2595-0118.20180049","article-title":"The current treatment of fibromyalgia","volume":"1","author":"Oliveira J\u00fanior JO","year":"2018","unstructured":"Oliveira J\u00fanior JO, Almeida MB. The current treatment of fibromyalgia. BrJP. 2018, 1:255-62. 10.5935\/2595-0118.20180049","journal-title":"BrJP"},{"key":"ref23","article-title":"Use of psychotropic drugs in the treatment of fibromyalgia: a systematic review","volume":"31","author":"Ferreira da Costa AV","year":"2021","unstructured":"Ferreira da Costa AV, de Carvalho Bezerra L, dos Anjos de Paula J. Use of psychotropic drugs in the treatment of fibromyalgia: a systematic review. Revista Brasileira de Crescimento e Desenvolvimento Humano. 2021, 31:12228.","journal-title":"Revista Brasileira de Crescimento e Desenvolvimento Humano"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i52B33601","article-title":"Updated treatment of fibromyalgia syndrome: a review","volume":"33","author":"Ibrahim AA","year":"2021","unstructured":"Ibrahim AA, AlMutairi MH, ALMutairi AF. Updated treatment of fibromyalgia syndrome: a review. J Pharm Res Int. 2021, 33:72-9. 10.9734\/jpri\/2021\/v33i52B33601","journal-title":"J Pharm Res Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1450743","article-title":"An evidence-based review of pregabalin for the treatment of fibromyalgia","volume":"34","author":"Arnold LM","year":"2018","unstructured":"Arnold LM, Choy E, Clauw DJ, et al.. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin. 2018, 34:1397-409. 10.1080\/03007995.2018.1450743","journal-title":"Curr Med Res Opin"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.11606\/issn.2317-0190.v29i3a178254","article-title":"Effect of pharmacotherapy on fibromyalgia: an overview of systematic reviews","volume":"29","author":"Costa AT","year":"2022","unstructured":"Costa AT, Figueiredo RF, Silva RD. Effect of pharmacotherapy on fibromyalgia: an overview of systematic reviews. Acta Fisiatrica. 2022, 29:232-44. 10.11606\/issn.2317-0190.v29i3a178254","journal-title":"Acta Fisiatrica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05135-y","article-title":"Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort","volume":"42","author":"Mehta P","year":"2022","unstructured":"Mehta P, Basu A, Ahmed S. Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort. Rheumatol Int. 2022, 42:1549-54. 10.1007\/s00296-022-05135-y","journal-title":"Rheumatol Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v11i9.31684","article-title":"Therapeutic interventions associated with improvements in the quality of life of patients with fibromyalgia: a systematic review","volume":"11","author":"Santos TC","year":"2022","unstructured":"Santos TC, Gomes IA, dos Passos Menezes P. Therapeutic interventions associated with improvements in the quality of life of patients with fibromyalgia: a systematic review. Res Soc Dev. 2022, 11:e23511931684. 10.33448\/rsd-v11i9.31684","journal-title":"Res Soc Dev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/327024-pain-management-in-fibromyalgia-evaluating-the-roles-of-pregabalin-duloxetine-and-milnacipran","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:07:28Z","timestamp":1735560448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/327024-pain-management-in-fibromyalgia-evaluating-the-roles-of-pregabalin-duloxetine-and-milnacipran"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.76631","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,30]]}}}